115 related articles for article (PubMed ID: 2963603)
1. Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients.
Miller-Graziano CL; Fink M; Wu JY; Szabo G; Kodys K
Arch Surg; 1988 Mar; 123(3):293-9. PubMed ID: 2963603
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma.
Faist E; Mewes A; Baker CC; Strasser T; Alkan SS; Rieber P; Heberer G
J Trauma; 1987 Aug; 27(8):837-48. PubMed ID: 2956432
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostaglandin E2 and plasminogen activator by various immunomodulators in human monocytes.
Homo-Delarche F; de Saint-Basile G; Le Deist F; Smets P; Griscelli C
Prostaglandins Leukot Med; 1986 Mar; 21(3):279-97. PubMed ID: 3517884
[TBL] [Abstract][Full Text] [Related]
4. Elevated tumor necrosis factor alpha production concomitant to elevated prostaglandin E2 production by trauma patients' monocytes.
Takayama TK; Miller C; Szabo G
Arch Surg; 1990 Jan; 125(1):29-35. PubMed ID: 2104744
[TBL] [Abstract][Full Text] [Related]
5. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
Koster FT; Williams JC; Goodwin JS
J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 regulation of human specific B-cell response: interaction with a monocyte product.
Emilie D; Crevon MC; Galanaud P
Clin Immunol Immunopathol; 1983 Dec; 29(3):415-23. PubMed ID: 6227436
[TBL] [Abstract][Full Text] [Related]
7. Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression.
Miller-Graziano CL; Szabo G; Griffey K; Mehta B; Kodys K; Catalano D
J Clin Immunol; 1991 Mar; 11(2):95-102. PubMed ID: 1905306
[TBL] [Abstract][Full Text] [Related]
8. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
Fischer A; Durandy A; Griscelli C
J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
[TBL] [Abstract][Full Text] [Related]
9. The role of prostaglandin E2 in immune suppression following injury.
Grbic JT; Mannick JA; Gough DB; Rodrick ML
Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
[TBL] [Abstract][Full Text] [Related]
10. Alteration of monocyte function following major injury.
Faist E; Mewes A; Strasser T; Walz A; Alkan S; Baker C; Ertel W; Heberer G
Arch Surg; 1988 Mar; 123(3):287-92. PubMed ID: 3124800
[TBL] [Abstract][Full Text] [Related]
11. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients. I. Role of Fc gamma RI cross-linking stimulation.
Szabo G; Kodys K; Miller-Graziano CL
J Clin Immunol; 1991 Nov; 11(6):326-35. PubMed ID: 1837029
[TBL] [Abstract][Full Text] [Related]
12. Lack of prostaglandin E2-mediated monocyte suppressive activity in newborn and mothers.
Fischer A; Durandy A; Mamas S; McCall E; Dray F; Griscelli C
Clin Exp Immunol; 1982 Aug; 49(2):377-85. PubMed ID: 6215198
[TBL] [Abstract][Full Text] [Related]
13. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
Balch CM; Dougherty PA; Tilden AB
Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
[TBL] [Abstract][Full Text] [Related]
14. Aberrations in post-trauma monocyte (MO) subpopulation: role in septic shock syndrome.
Miller-Graziano CL; Szabo G; Kodys K; Griffey K
J Trauma; 1990 Dec; 30(12 Suppl):S86-96. PubMed ID: 2254998
[TBL] [Abstract][Full Text] [Related]
15. The influence of major trauma on the regulatory levels of interleukin-1 (IL-1) and IL-2 in human mononuclear leukocytes.
Faist E; Schinkel C; Zimmer S; Kremer JP; Alkan S; Rordorf C; von Donnersmarck H; Schildberg FW
Zentralbl Chir; 1993; 118(7):420-31. PubMed ID: 8372524
[TBL] [Abstract][Full Text] [Related]
16. Separation of a population of human T lymphocytes that bind prostaglandin E2 and exert a suppressor activity.
Fischer A; Le Deist F; Durandy A; Griscelli C
J Immunol; 1985 Feb; 134(2):815-9. PubMed ID: 2856929
[TBL] [Abstract][Full Text] [Related]
17. Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets.
Khansari N; Chou YK; Fudenberg HH
Eur J Immunol; 1985 Jan; 15(1):48-51. PubMed ID: 3871396
[TBL] [Abstract][Full Text] [Related]
18. Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma.
Yokota M; Sakamoto S; Koga S; Ibayashi H
Clin Exp Immunol; 1987 Feb; 67(2):335-42. PubMed ID: 3038436
[TBL] [Abstract][Full Text] [Related]
19. Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins.
Berlinger NT
Laryngoscope; 1984 Nov; 94(11 Pt 1):1407-10. PubMed ID: 6593559
[TBL] [Abstract][Full Text] [Related]
20. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
